(Q83178024)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16625311%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Reductions in overactive bladder-related incontinence from pooled analysis of phase III trials evaluating treatment with solifenacin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16625311%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

main subject

phase III clinical trial

1 reference

Linda Cardozo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16625311%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

David Castro-Diaz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16625311%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Marc Gittelman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16625311%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Arwin Ridder

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16625311%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Moses Huang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16625311%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

20 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16625311%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16625311%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16625311%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

512-519

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16625311%20AND%20SRC:MED&resulttype=core&format=json

The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society

19 January 2020

cites work

1 reference

12 December 2020

The prevalence of overactive bladder.

1 reference

12 December 2020

Prevalence and burden of overactive bladder in the United States

1 reference

12 December 2020

Costs of urinary incontinence and overactive bladder in the United States: a comparative study.

1 reference

12 December 2020

Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder

1 reference

12 December 2020

The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey

1 reference

12 December 2020

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

1 reference

12 December 2020

Economic considerations and outcome measurement in urge incontinence.

1 reference

12 December 2020

Geriatric considerations in the diagnosis and management of overactive bladder.

1 reference

12 December 2020

The impact on health‐related quality of life of stress, urge and mixed urinary incontinence

1 reference

12 December 2020

Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial

1 reference

12 December 2020

Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder

1 reference

12 December 2020

10.1007/S00192-005-0058-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16625311%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference